A high rate of venous thromboembolism in a multi‐institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma
Year: 2002
Type: article
Study design: Clinical Trial
Source: Cancer
DOI: 10.1002/cncr.10847
Institutions: University of Chicago, Weiss Memorial Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2062302016
